北京招聘

-
1.Act as the key point of contact as biomarker scientist to the clinical study team;
2.Delivers high quality biomarker strategies for target
engagement, pharmacodynamics endpoints, patient
selection and companion diagnostic development (where appropriate) at study level;
3.Ensure alignment of biomarker strategies with clinical
operational plans with functional area capabilities;
4.Lead the writing and editing of the biomarker sections of the clinical protocol;
5.Ensure successful implementation of biomarker
strategies including assessment of biomarker research
proposals, study procedure determination to ensure
accurate and appropriate sample collection, consentforms and Human Biological Sample Management
review to ensure its alignment with the protocol, data
standards determination to ensure appropriate biomarker analysis, etc.;
6.Serve as a point of contact for external vendors and
collaborators involved in the clinical study or translational
research and lead the biomarker vendor determination.
7.Evaluate new technologies to implement in clinical
studies to address emerging biomarker questions;
8.Lead the analyses of biomarker data, collaborating with statisticians, bio-informatics clinical and translational groups;
9.Lead the summary of study specific biomarker data, and present results for biomarker strategy to both internal and external groups;
10.Contribute to group’s awareness of the emerging key
scientific and technical innovations to help drive our
continuous improvement.
职位要求：
1.PhD in Life Science areas;
Experience in the biology research or drug development
process;
2.Understanding of the role of translational
research/medicine, clinical biomarker and companion
diagnostic development in drug development is preferred;
3.Demonstrated knowledge of oncology and/or
immunology disease biology, and various biomarker
platforms (such as IHC, flow cytometry, NGS, liquid
biopsy, etc.) and their clinical practice;
4.Demonstrated ability to work in a matrix environment;
Ability to multitask across multiple development assets;
5.Proven ability to frame issues, ask the right clarifying
questions, and rationalize decisions.

百济神州是一家立足于科学的全球性生物科技公司，专注于开发创新、可负担的药物，旨在为全球患者改善治疗效果，提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作，加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。